Chang J C, Slutzker B, Lindsay N
Am J Med Sci. 1978 May-Jun;275(3):345-51. doi: 10.1097/00000441-197805000-00012.
A 53-year-old male with a long-standing idiopathic pure red cell aplasia, refractory to testosterone cypionate, fluoxymesterone, and corticosteroid, was successfully treated with oxymetholone. Blood count, bone marrow, reticuloendothelial bone marrow scan, and ferrokinetic studies showed a marked increase of erythropoiesis in response to oxymetholone. The patient became hematologically normal within 12 weeks and has required no further transfusions. This observation suggests possible difference of mechanisms in the action of various androgenic drugs. It also suggests that failure of response to one androgenic agent does not necessarily mean the other androgenic agents will not be effective in cases of refractory idiopathic pure red cell aplasia.
一名53岁男性,患有长期特发性纯红细胞再生障碍性贫血,对环戊丙酸睾酮、氟甲睾酮和皮质类固醇治疗无效,使用羟甲烯龙治疗成功。血细胞计数、骨髓检查、网状内皮系统骨髓扫描和铁动力学研究显示,使用羟甲烯龙后红细胞生成显著增加。患者在12周内血液学恢复正常,无需进一步输血。该观察结果提示各种雄激素药物作用机制可能存在差异。这也表明,在难治性特发性纯红细胞再生障碍性贫血病例中,对一种雄激素药物无反应并不一定意味着其他雄激素药物也无效。